Acro Biomedical Changes Certifying Accountant
Ticker: ACBM · Form: 8-K · Filed: Jul 2, 2025 · CIK: 1622996
| Field | Detail |
|---|---|
| Company | Acro Biomedical CO., LTD. (ACBM) |
| Form Type | 8-K |
| Filed Date | Jul 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, accounting
TL;DR
ACRO BIOMEDICAL swapped auditors from WithumSmith+Brown to BDO USA, effective June 30, 2025.
AI Summary
On July 1, 2025, ACRO BIOMEDICAL CO., LTD. filed an 8-K report indicating a change in its certifying accountant. The company previously engaged WithumSmith+Brown, PC, but has now appointed BDO USA, P.A. as its new independent registered public accounting firm. This change was effective as of June 30, 2025.
Why It Matters
A change in a company's auditor can signal shifts in financial reporting scrutiny or strategic direction, potentially impacting investor confidence.
Risk Assessment
Risk Level: low — The filing solely reports a change in the company's auditor, which is a routine administrative event.
Key Players & Entities
- ACRO BIOMEDICAL CO., LTD. (company) — Registrant
- WithumSmith+Brown, PC (company) — Former Certifying Accountant
- BDO USA, P.A. (company) — New Certifying Accountant
- July 1, 2025 (date) — Report Date
- June 30, 2025 (date) — Effective Date of Change
FAQ
Who was ACRO BIOMEDICAL CO., LTD.'s previous certifying accountant?
The previous certifying accountant for ACRO BIOMEDICAL CO., LTD. was WithumSmith+Brown, PC.
Who is ACRO BIOMEDICAL CO., LTD.'s new independent registered public accounting firm?
BDO USA, P.A. has been appointed as the new independent registered public accounting firm for ACRO BIOMEDICAL CO., LTD.
When did the change in certifying accountant become effective?
The change in certifying accountant became effective as of June 30, 2025.
What type of filing is this for ACRO BIOMEDICAL CO., LTD.?
This is a Form 8-K filing, reporting current information.
What specific item information is being reported in this 8-K?
This 8-K filing reports changes in the registrant's certifying accountant and includes financial statements and exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 2, 2025 regarding ACRO BIOMEDICAL CO., LTD. (ACBM).